技术与方法 |
|
|
|
|
连续流层析技术在亲和层析中的应用及生产放大评估 |
张玲(),曹小丹,杨海旭,李文蕾 |
天士力生物医药股份有限公司 天津 300410 |
|
The Application of Continuous Purification in Affinity Chromatography and Evaluation of Production Scale-up |
ZHANG Ling(),CAO Xiao-dan,YANG Hai-xu,LI Wen-lei |
Tasly Biophamaceuticals Co., Ltd., Tianjin 300410, China |
引用本文:
张玲,曹小丹,杨海旭,李文蕾. 连续流层析技术在亲和层析中的应用及生产放大评估[J]. 中国生物工程杂志, 2021, 41(6): 38-44.
ZHANG Ling,CAO Xiao-dan,YANG Hai-xu,LI Wen-lei. The Application of Continuous Purification in Affinity Chromatography and Evaluation of Production Scale-up. China Biotechnology, 2021, 41(6): 38-44.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2102024
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I6/38
|
[1] |
Fisher A C, Kamga M H, Agarabi C, et al. The current scientific and regulatory landscape in advancing integrated continuous biopharmaceutical manufacturing. Trends in Biotechnology, 2019, 37(3):253-267.
doi: S0167-7799(18)30248-8
pmid: 30241924
|
[2] |
Pollock J, Ho S V, Farid S S. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty. Biotechnology and Bioengineering, 2013, 110(1):206-219.
doi: 10.1002/bit.24608
pmid: 22806692
|
[3] |
Klutz S, Magnus J, Lobedann M, et al. Developing the biofacility of the future based on continuous processing and single-use technology. Journal of Biotechnology, 2015, 213:120-130.
doi: 10.1016/j.jbiotec.2015.06.388
|
[4] |
Konstantinov K B, Cooney C L. White paper on continuous bioprocessing may 20-21 2014 continuous manufacturing symposium. Journal of Pharmaceutical Sciences, 2015, 104(3):813-820.
doi: 10.1002/jps.24268
pmid: 25417595
|
[5] |
Moore C M V. Continuous manufacturing - FDA perspective on submissions and implementation. [2011-09-13]. http://www.pqri.org/workshops/SampleSize/Moore.pdf.
|
[6] |
Chatterjee S. “FDA Perspective on Continuous Manufacturing”, presented at IFPAC Annual Meeting. [2012-01-01].https://www.fda.gov/media/85366/download.
|
[7] |
US FDA. Draft guidance for industry: quality considerations for continuous manufacturing. [2019-02-01].https://www.fda.gov/media/121314/downloa.
|
[8] |
Bisschops M. BioSMBTM technology: continuous countercurrent chromatography enabling a fully disposable process. Biopharmaceutical Production Technology. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2012: 769-791.
|
[9] |
Bisschops M, Brower M. The impact of continuous multicolumn chromatography on biomanufacturing efficiency. Pharmaceutical Bioprocessing, 2013, 1(4):361-372.
doi: 10.4155/pbp.13.46
|
[10] |
Godawat R, Brower K, Jain S, et al. Periodic counter-current chromatography:design and operational considerations for integrated and continuous purification of proteins. Biotechnology Journal, 2012, 7(12):1496-1508.
doi: 10.1002/biot.201200068
pmid: 23070975
|
[11] |
Aumann L, Morbidelli M. A continuous multicolumn countercurrent solvent gradient purification (MCSGP) process. Biotechnology and Bioengineering, 2007, 98(5):1043-1055.
doi: 10.1002/(ISSN)1097-0290
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|